Back to search
FDAFDA · Food and drugs·Recall number Z-0148-2015

siemens Dimension® Phenytoin Flex® Reagent Cartridge The PTN method used on the Dimension® clinical chemistry system is an in vitro diagnostic test intended to measure phenytoin (dilantin, diphenylhydantoin), an anti-epileptic drug, in human serum and plasma. PTN test results are used in the diagnosis and treatment of phenytoin overdose and in monitoring levels of phenytoin to ensure appropriate therapy.

Published November 5, 2014 · Recall initiated: September 24, 2014

Summary

FDA records medical device Class II recall Z-0148-2015, published November 5, 2014 and initiated September 24, 2014. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Terminated; Reported quantity: 1733; Lot: lot FA5154, exp. 2015-06-03. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Internal testing has confirmed a low absorbance range between the levels 1 and 5 calibrators with this lot resulting in the potential for a positive or negative bias and imprecision across the PTN assay range.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
Worldwide Distribution - USA (nationwide) including Puerto Rico., and the countries of Australia, Brazil, Bahamas, Canada, Chile, India, Japan and Uruguay
Lot
lot FA5154, exp. 2015-06-03
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was siemens Dimension® Phenytoin Flex® Reagent Cartridge The PTN method used on the Dimension® clinical chemistry system is an in vitro diagnostic test intended to measure phenytoin (dilantin, diphenylhydantoin), an anti-epileptic drug, in human serum and plasma. PTN test results are used in the diagnosis and treatment of phenytoin overdose and in monitoring levels of phenytoin to ensure appropriate therapy. recalled?

Yes. FDA published recall Z-0148-2015 on November 5, 2014. Reported hazard: Internal testing has confirmed a low absorbance range between the levels 1 and 5 calibrators with this lot resulting in the potential for a positive or negative bias and imprecision across the PTN assay range.

What should I do if I have this product?

Voluntary: Firm initiated · Letter